A Thailand patent on the Anti-CεmX (FB825) antibody was granted

Published Date:2025-09-17

Statement
No	1	Date of announcement	2025/09/17	Time of announcement	15:55:15
Subject	A Thailand patent on the Anti-CεmX (FB825) antibody was granted
To which item it meets	Subparagraph 53			Date of events	2025/09/17
1.Date of occurrence of the event:2025/09/17 2.Company name:ONENESS BIOTECH CO., LTD 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office 4.Reciprocal shareholding ratios:NA 5.Cause of occurrence: The Company has been informed by the patent agency that a Thailand patent titled“ANTI-CεMX ANTIBODIES CAPABLE OF BINDING TO HUMAN MIGE ON BLYMPHOCYTES”has been granted on humanized anti-CεmX monoclonal antibody (FB825) under the patent number 109715. 6.Countermeasures:None 7.Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.): The assignee of the above-mentioned patent is Academia Sinica. Oneness Biotech owns the exclusive worldwide right of the patent for manufacture, use, and sale of the product.